Stock Analiz

Inhibrx Biosciences, Inc. (INBX) stock forecast and price target

Price $83.30 · data as of November 13, 2026

12-month price target

Average target$266.67
Upside / downside+220.1%
Analysts3
ConsensusStrong buy
Low $230.00Average $266.67High $325.00

Gold marker: average target · white marker: today’s price ($83.30)

Analyst ratings

Strong buy 0Buy 3Hold 1Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-9.26−2.4%$0
Next fiscal year
ends December 31, 2027
$-8.76+5.3%$32M
Next quarter
ends December 31, 2026
$-2.42−14.4%$0
Quarter after
ends March 31, 2027
$-2.37−10.2%$1M

Consensus of the analysts covering Inhibrx Biosciences, updated daily. In the last 30 days 0 estimates were raised and 1 lowered.

Frequently asked questions

What is the Inhibrx Biosciences stock price target?

The average 12-month target from 3 analysts is $266.67, 220.1% above the current price of $83.30 Targets range from $230.00 to $325.00.

Is Inhibrx Biosciences a buy according to analysts?

The consensus rating is “Strong buy” (3 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Inhibrx Biosciences expected to earn?

Analysts expect EPS of $-9.26 for the fiscal year ending December 31, 2026 and $-8.76 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.